ADMA FY 2013 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+174.4% YoY

Gross Profit

$1M34.0% margin

Operating Income

-$15M-490.4% margin

Net Income

-$16M-506.2% margin

EPS (Diluted)

$-2.38

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$888,295

Balance Sheet

Total Assets

$32M

Total Liabilities

$10M

Stockholders' Equity

$22M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$1M	+174.4%
Gross Profit	$1M	$449,062	+132.5%
Operating Income	-$15M	-$8M	-90.2%
Net Income	-$16M	-$7M	-112.7%